author-photo

Linda Jolliffe

Johnson & Johnson Pharmaceutical Research and Development

20

Papers

934

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

Erythropoietin for the Treatment of Acute Ischemic Stroke: Preclinical Rationale

2006
Show All
- Source
- Cite
- Save
Citations (0)
Potential involvement of BMP receptor type IB activation in a synergistic effect of chondrogenic promotion between rhTGFbeta3 and rhGDF5 or rhBMP7 in human mesenchymal stem cells.

2006 Growth Factors Journal
Show All
- Source
- Cite
- Save
Citations (31)
3-Acyl-2,6-diaminopyridines as cyclin-dependent kinase inhibitors: synthesis and biological evaluation

2005 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (20)
Erythropoietin Did Not Activate the JAK/STAT or the ERK1/2 Pathway in the Human Colorectal Cell Line, HT-29.

2004 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Development of an In Vivo Model To Assess Factors That May Stimulate the Generation of an Immune Reaction to Epoetin Alfa.

2004 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.

2002 The Journal of Rheumatology
Show All
- Source
- Cite
- Save
Citations (128)
Erythropoietin induces changes in gene expression in PC-12 cells.

2002 Molecular Brain Research
Show All
- Source
- Cite
- Save
Citations (54)
In Vitro Characterization of Five Humanized OKT3 Effector Function Variant Antibodies

2000 Cellular Immunology
Show All
- Source
- Cite
- Save
Citations (171)
Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A.

1996 Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (45)
A non-activating humanized anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo

1994 Transplantation
Show All
- Source
- Cite
- Save
Citations (158)